Recent analysis with xCell reveals that plasma cells and CD4+ Tcm in the tumor microenvironment may play a role in the progression of triple-negative breast cancer (Deng et al., 2019), although only immune cells were investigated. This evidence concerns the gene CD4 and triple-negative breast carcinoma.